A new study identified GPR84 as a driver of lung inflammation through PANoptosome activation in the context of influenza A virus infection. Researchers mapped a mechanistic chain linking the receptor to downstream inflammatory cell death and amplification pathways, sharpening the biological understanding of how respiratory inflammation escalates during viral challenge. By targeting a specific inflammation axis rather than broadly suppressing immunity, the findings may inform host-directed therapeutic strategies for severe respiratory viral disease. The work also adds an immune-death mechanism layer—PANoptosis, a coordinated form of cell death spanning multiple pathways—that can be leveraged in future intervention designs. The study’s emphasis on a defined receptor-to-pathway link increases the potential for more targeted preclinical follow-ups.